Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the schedule hereto:
Schedule
Product: Daivonex
Active Ingredient: Calcipotriol 50Ág/g
Dosage Form: Topical ointment
New Zealand Sponsor: CSL (New Zealand) Limited
Manufacturer: Leo Laboratories Limited, Crumlin, Dublin, Eire
Dated this 22nd day of October 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go7210